ME-20-0025
CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency.
Section 1135 Waiver Flexibilities - Wyoming Coronavirus Disease 2019 (Third Request)
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Wyoming for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Wyoming’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Collections:
Section 1135 Waiver Flexibilities - Oklahoma Coronavirus Disease 2019 (Sixth Request)
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Oklahoma for multiple section 1135 flexibilities on March 24, 2020. Your follow-up communication to CMS on January 19, 2021 detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Oklahoma and requested a waiver or modification of those additional requirements.
Collections:
Section 1135 Waiver Flexibilities - Nebraska Coronavirus Disease 2019 (Third Request)
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Nebraska for multiple section 1135 flexibilities on April 2, 2020. Your follow-up communication to CMS on January 14, 2021, indicated Nebraska’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Collections:
Section 1135 Waiver Flexibilities - Kansas Coronavirus Disease 2019 (Third Request)
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Kansas for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 7, 2021, indicated Kansas’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Collections:
Section 1135 Waiver Flexibilities - Colorado Coronavirus Disease 2019 (Third Request)
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Colorado for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 12, 2021, indicated Colorado’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Collections:
Section 1135 Waiver Flexibilities - Arizona Coronavirus Disease 2019 (11th Request)
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Arizona for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communications to CMS on February 12, 2021 and March 16, 2021 indicated Arizona’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Collections:
NJ-20-0029
This SPA demonstrates the state’s compliance with section 5022 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act.